Anti-D production induced by DEL type blood in Rh (D) negative patients and blood matching incompatibility
-
摘要: 分析1例Rh(D)阴性患者输注DEL型血后产生高效价抗-D致交叉配血不合的原因,为Rh(D)阴性患者安全输血提供策略建议。采用盐水试管法和微柱凝胶抗人球蛋白法进行不规则抗体筛查和性质鉴定,采用微柱凝胶抗人球蛋白法对不规则抗体进行特异性鉴定和效价测定;将配血不合红细胞与患者血清在37℃温吸收后在56℃热放散,对所得放散液采用微柱凝胶抗人球蛋白法进行抗体特异性鉴定,同时采用吸收放散法对献血员红细胞进行DEL型检测。患者血清中不规则抗体筛查结果为阳性,抗体性质为IgG型,抗体特异性为抗-D,效价为2 048,配血不合红细胞吸收放散液抗体特异性鉴定为抗-D,经吸收放散检测该献血员为DEL型(回顾调查该患者在17 d前输注的一袋红细胞也为DEL型)。Rh(D)阴性患者接受DEL型血输注,具有产生抗-D的潜在风险,所产生的抗-D可再次结合DEL型红细胞致配血不合。对于有输血史、妊娠史、有生育要求的女性以及输血依赖等群体输注应持谨慎态度。对已经产生抗-D患者,在非紧急情况不应输注,避免溶血性输血不良反应的发生,提高输血的安全性和有效性。Abstract: To analyze the cause of cross matching incompatibility caused by high titer antibody D after infusion of DEL type blood in a Rh(D) negative patient, and provide strategic recommendations for safe blood transfusion in Rh(D) negative patients. The irregular antibodies were screened and identified by brine test tube method and microcolumn gel anti human globulin method, and the irregular antibodies were specifically identified and titer determined by microcolumn gel anti human globulin method. The mismatched red blood cells and the patient's serum were absorbed at 37℃ and then dissipated at 56℃. The obtained diffusion solution was identified by microcolumn gel anti human globulin method for antibody specificity. At the same time, the blood donors' red blood cells were detected for DEL type by absorption and diffusion method. The screening result for irregular antibodies in the patient's serum was positive, and the nature of the antibody was IgG type. The specificity of the antibody was anti-D, with a titer of 2 048. The specificity of the red blood cell absorption and release solution antibody was identified as anti-D. After absorption and release testing, the donor was classified as DEL type(a retrospective investigation showed that the red blood cells transfused by this patient 17 days ago were also DEL type). The infusion of DEL type blood into Rh(D) negative patients carried a potential risk of inducing the production of anti-D, which could be combined with DEL type red blood cells again to cause incompatibility. For women with a history of blood transfusion, pregnancy or fertility requirements and patients with blood transfusion dependence, transfusion should be cautious. As for those who have already developed anti-D, transfusion should only be performed in emergency situations to avoid the occurrence of hemolytic transfusion adverse reactions, and improve the safety and effectiveness of blood transfusion.
-
Key words:
- DEL type /
- anti-D /
- absorption and dissipation test /
- Rh blood type /
- cross matching
-
表 1 患者就诊期间配发血情况表
日期 献血员 血型 血量/U 配血结果 抗筛结查 抗体鉴定 2月19日 献血员1 A型,Rh阴性 2 相合 阴性 2月21日 献血员2 A型,Rh阴性 2 相合 3月7日 献血员3 A型,Rh阴性 1 相合 阳性 抗-D 献血员4 A型,Rh阴性 2 相合 3月8日(择期手术备血) 献血员5 A型,Rh阴性 2 不合 阳性 抗-D 献血员6 A型,Rh阴性 2 相合 献血员7 A型,Rh阴性 1 相合 献血员8 A型,Rh阴性 2 相合 表 2 患者血清不规则抗体筛查格局
编号 Rh Kidd MNs Duffy D C E c e Cw Jka Jkb M N S s Fya Fyb Ⅰ + + - - + - + - - + - + - + Ⅱ + - + + - - - + + - + + + - Ⅲ + + + + + - + + + - + + + + 编号 RhKell Lewis P Xg Lutheran Diego 结果 K k Kpa Kpb Lea Leb P1 Xga Lua Lub Dia NS IAT Ⅰ - + - + + - - + - + - 0 4+ Ⅱ + + - + - + - - - + - 0 4+ Ⅲ + + - + - + + + - + - 0 4+ 表 3 患者血清(或献血员细胞放散液)抗体特异性鉴定格局表
编号 RH Lewis MNSsMur Kidd D C c E e Cw lea leb M N S s Mur Jka Jkb 1 + + 0 + + 0 0 + 0 + 0 + 0 0 + 2 + + 0 0 + + 0 + + 0 0 + 0 + + 3 + 0 + + 0 0 0 + + 0 + + 0 + + 4 + 0 + 0 + 0 0 0 + + 0 + 0 + + 5 0 + + 0 + 0 0 + + + 0 + 0 0 + 6 0 0 + + + 0 + 0 + + + + 0 + 0 7 0 0 + 0 + 0 + 0 0 + 0 + 0 0 + 8 0 0 + 0 + 0 0 + + 0 0 + 0 + 0 9 + + + 0 + 0 + W + + 0 + + + 0 10 + + 0 0 + 0 + 0 0 + + 0 0 + 0 11 + W + + 0 0 0 + + 0 0 + 0 + + 12 0 0 + 0 + 0 + 0 + + 0 + 0 0 + 13 0 0 + 0 + 0 0 + + + + + 0 + 0 14 0 0 + 0 + 0 0 0 + + 0 + 0 0 + 15 0 0 + 0 + 0 0 + + 0 + 0 0 0 + 16 + + + + + 0 0 + + + 0 + + 0 + 编号 Duffy P1 Xg Dia Kell Lutherar 抗体鉴定结果 Fya Fyb P1 Xga Dia K k Kpa Kpb Jsa Jsb Lua Lub 患者血清 献血员细胞放散液 1 0 + + + 0 0 + 0 + 0 + 0 + 2+ 2+ 2 + 0 0 + 0 0 + 0 + 0 + 0 + 2+ 2+ 3 0 + 0 + 0 0 + 0 + 0 + 0 + 2+ 2+ 4 0 0 + 0 0 0 + 0 + 0 + 0 + 2+ 2+ 5 0 + + + 0 0 + 0 + 0 + 0 + 0 0 6 + + 0 + 0 0 + 0 + 0 + 0 + 0 0 7 0 + + + 0 + + 0 + 0 + 0 + 0 0 8 + 0 + + 0 0 + 0 + 0 + 0 + 0 0 9 + 0 + 0 0 0 + 0 + 0 + 0 + 2+ 2+ 10 0 + + + 0 + + 0 + 0 + 0 + 2+ 2+ 11 + 0 + + + 0 + 0 + 0 + 0 + 2+ 2+ 12 + + + + 0 + + 0 + 0 + + 0 0 0 13 + 0 0 + 0 0 + 0 + 0 + 0 + 0 0 14 0 + 0 + 0 0 + 0 + 0 + 0 + 0 0 15 0 + + + 0 0 + 0 + 0 + 0 + 0 0 16 + 0 0 + 0 0 + 0 + 0 + 0 + 2+ 2+ 自身对照 0 表 4 献血员5和献血员6 DEL型检测格局表
人员 放散液(IAT) 洗涤液(IAT) O1细胞 O2细胞 O3细胞 O1细胞 O2细胞 O3细胞 献血员5(配血不合) + + + 0 0 0 献血员6(配血相合) 0 0 0 0 0 0 -
[1] Okubo Y, Yamaguchi H, Tomita T, et al. A D variant, del?[J]. Transfusion, 1984, 24(6): 542.
[2] 周赟, 代静, 蔡兰, 等. 无偿献血人群RhD阴性血型分布研究[J]. 临床血液学杂志, 2023, 36(8): 545-547. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2023.08.003
[3] 刘太香, 薛敏, 许进明, 等. 变异型D产生抗-D合并抗-C及抗-Jkb抗体1例[J]. 临床血液学杂志, 2023, 36(2): 137-139. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2023.02.014
[4] Wagner T, Körmöczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells[J]. Transfusion, 2005, 45(4): 520-526. doi: 10.1111/j.0041-1132.2005.04256.x
[5] 邵超鹏, 苏宇清, 熊文, 等. DEL红细胞膜D抗原表位分析[J]. 国际输血及血液学杂志, 2006, 29(3): 193-195.
[6] Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans[J]. BMC Genet, 2001, 2: 10.
[7] Okuda H, Kawano M, Iwamoto S, et al. The RHD gene is highly detectable in RhD-negative Japanese donors[J]. J Clin Invest, 1997, 100(2): 373-379. doi: 10.1172/JCI119543
[8] 杨红梅, 邹昕, 虞茜, 等. 常州地区RHD变异型基因分型及特征分析[J]. 临床血液学杂志, 2022, 35(10): 739-743. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2022.10.011
[9] Ji YL, Luo YL, Wen JZ, et al. Patients with Asian-type DEL can safely be transfused with RhD-positive blood[J]. Blood, 2023, 141(17): 2141-2150.
[10] Yasuda H, Ohto H, Sakuma S, et al. Secondary anti-D immunization by Del red blood cells[J]. Transfusion, 2005, 45(10): 1581-1584. doi: 10.1111/j.1537-2995.2005.00579.x
[11] St-Louis M, Lebrun A, Goldman M, et al. Alloimmunization of patients by blood units harboring distinct DEL variants[J]. Immunohematology, 2013, 29(4): 136-140. doi: 10.21307/immunohematology-2019-136
[12] Kim KH, Kim KE, Woo KS, et al. Primary anti-D immunization by DEL red blood cells[J]. Ann Lab Med, 2009, 29(4): 361-365. doi: 10.3343/kjlm.2009.29.4.361
[13] Yang HS, Lee MY, Park TS, et al. Primary anti-D alloimmunization induced by "Asian type" RHD(c. 1227G>A)DEL red cell transfusion[J]. Ann Lab Med, 2015, 35(5): 554-556. doi: 10.3343/alm.2015.35.5.554
[14] Safic Stanic H, Dogic V, Bingulac-Popovic J, et al. RhD alloimmunization by DEL variant missed in donor testing[J]. Transfusion, 2022, 62(5): 1084-1088. doi: 10.1111/trf.16862
[15] 冯双利, 卢志芬, 刘则红. 33名RhD(-)无关献血者中Del的检测分析[J]. 中国输血杂志, 2001, 14(5): 307.
[16] 蒋玉林, 毛伟, 刘不尽, 等. RhD阴性受血者输注DEL型血液诱发抗-D1例[J]. 中国输血杂志, 2021, 34(3): 308-311.